Global Discovery Biosciences (GD Biosciences), developer of The PULS Cardiac Test, a 9-protein biomarker based blood test that detects and diagnoses early-stage heart disease in asymptomatic patients, today announced its strategic partnership with The Natural Doctor to help bring prevention and enhanced detection methods direct to London, UK. The announcement is part of a strategic international expansion plan. The company launched the PULS Cardiac Test in India just last month.
“The PULS Cardiac Test is a powerful diagnostic and predictive assessment that has demonstrated significant improvement in identifying patients with early stage cardiac lesions and has been validated in a multi-ethnic population,” said Douglas S. Harrington, M.D., CEO of GD Biosciences and co-developer of the PULS Cardiac Test. “With its ongoing success in the U.S., the PULS Cardiac Test aims to catalyze improved cardiac disease detection and management around the world.”
The PULS Cardiac Test has seen significant growth in the U.S. since its launch earlier this year. As an affordable blood test, reimbursed by most healthcare insurance in the US, it is a breakthrough in disease management and prevention.
Eighty percent of heart disease is preventable through healthy lifestyle choices, education and early detection.
Dr. Nyjon Eccles, founder of the Natural Doctor in London UK, comments:
“Since 1998, I have been practicing Preventative Medicine. The Medical profession tends to use tests that are not sensitive enough for early detection, hence, we tend to detect disease late in the day when it is well established. Fifty percent of people who have a heart attack have normal cholesterol levels and this highlights the fact that the current cardiovascular risk blood markers that we doctors use are missing a large proportion of people at risk. I believe that the PULS Cardiac Test will prove a game-changer in this respect”.
“The Natural Doctor is excited to be working with GD biosciences, since part of our mission is to help prevent diseases through early detection, education and offering non-invasive, cost effective solutions to keep people away from diseases like heart disease”.
The Natural Doctor will be the sole representative of GD Biosciences for their PULS Cardiac Test in the UK.
Anyone interested in knowing more about this test can email queries to firstname.lastname@example.org
About GD Biosciences:
Global Discovery Biosciences is a pioneer in the field of diagnostic medicine. The company works on the cutting edge of medical research, turns discoveries into innovative products and brings those products to the global marketplace.
The company works with advanced research teams to develop, manufacture and distribute innovative technology platforms to address the needs of the global disease burden. Its CLIA-certified and GMP laboratory performs a menu of clinically effective tests targeting key health issues. Our goal is to equip physicians with the tools they need to transform health care – one patient at a time.
About the PULS Cardiac Test
The PULS Cardiac Test is a simple blood test that uses breakthrough medical technology to identify individuals with active, yet undetected subclinical Coronary Heart Disease (CHD), who are at risk of experiencing a Heart Attack, and for whom early intervention can help. Check out our recent news coverage:
Fox News Special Report – Technology Helps Predict Heart Attacks
Travel Pulse – Could Blood Test Warn Pilots of Heart Attack Risk?
Times Colonist – Blood test can assess heart attack risk, conference told
Saskatoon Star Phoenix – New test for heart attack risk
The Province – Blood test can assess heart attack risk, Vancouver conference hears
About The Natural Doctor (TND)
TND was formed by Dr. Nyjon Eccles and provides services in Wellness, Better Ageing, Cardiac Disease and Cancer Prevention, and Breast Health. This is accomplished by the use of natural molecules; both nutritional and hormones. Dr Eccles has co-developed a state-of-the-art computer-assisted Breast Thermography system to aid in early breast cancer detection. A key part of TND philosophy is early detection in general and natural corrective measures to prevent disease. Dr Eccles has already achieved promising results in changing breast health risk with the use of an early detection advantage. He is well recognised in the UK as one of the leading Integrated Medicine Physicians and for his pro-activeness in Health Education, Preventative Medicine and Health Empowerment. He lectures regularly in the UK and abroad on Preventative Medicine.
TND’s mission is to be instrumental in preventing and reversing disease, through continuous education, early detection and to provide alternative non-invasive natural affordable treatments.